---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-031598"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2021-12-15T23:59:59+00:00"
generated_at: "2026-06-28T01:06:27.633864+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oncotelic issues $0.75M in convertible notes at $0.07/sh; repays $307.5K Geneva Notes

## Summary
- Issued three convertible notes on Dec 9, 12, 15, 2021 totaling $0.75M gross; part of a $1.25M financing round.
- Notes bear 12% interest, mature in one year, convertible at $0.07 per share; prepayment permitted with 3 days' notice.
- Proceeds used for working capital, debt repayment, and payroll; restrictions on loans to officers/directors apply.
- Fully repaid May and June 2021 Geneva Notes ($203,750 + $103,750) with interest and prepayment penalty.
- JH Darbie & Co. receives 10% finder's fee in cash and warrants equal to 10% coverage at conversion price.

## SEC filing metadata
- accession: 0001493152-21-031598
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2021-12-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315221031598/0001493152-21-031598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315221031598/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-031598
- JSON: https://secwatch.observer/filing/0001493152-21-031598.json
- Plain text: https://secwatch.observer/filing/0001493152-21-031598.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.